ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2006;5:544-549. doi:10.1510/icvts.2006.136267
© 2006 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Guido Van Nooten
Kishan Narine
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Nooten, G.
Right arrow Articles by Narine, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Nooten, G.
Right arrow Articles by Narine, K.
Related Collections
Right arrow Valve disease

ESCVS article - Experimental

Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV® valves in the sheep model{star}

Guido Van Nootena,*, Pamela Somersa, Maria Cornelissenc, Stefaan Boucheza, Frank Gasthuysb, Eric Coxb, Lisa Sparksd and Kishan Narinea

a Department of Cardiac Surgery, 5K12, University Hospital Ghent, De Pintelaan 185, BE-9000 Ghent, Belgium
b Veterinary Medicine, Ghent University, Ghent, Belgium
c Histology and Human Anatomy, Ghent University, Ghent, Belgium
d Department of Cardiac Surgery, The Prince Charles Hospital, University of Queensland, Brisbane, Australia

*Corresponding author. Tel.: +32 9 240 4700; fax: +32 9 240 3882.

E-mail address: guido.vannooten{at}ugent.be (G. Van Nooten).

Aim of the study: A major limitation of currently available bioprosthetic valves is their propensity to calcify. At present, one approach in tissue-engineering, uses decellularized, xenogenic scaffolds that are implanted, with the expectation of complete matrix repopulation in vivo. Whether or not such a decellularized matrix will be sufficiently endowed to prevent calcification is unknown. Materials and methods: This study examines the calcification potential of xenogenic biological scaffolds from two species, namely pigs (n=3) and kangaroos (n=3) in the sheep model and compared them to a commercially available glutaraldehyde treated porcine bioprosthetic valve (Toronto SPV®) (n=3). Results: Valves and matrices were explanted after 120 days. Histologically (H&E and Von Kossa stain) more calcium was found in the acellular matrices. The mean calcium content (mg/g-dw) of the Toronto SPV® valve leaflets was 2.63 mg/g-dw compared to 43.81 mg/g-dw (P=0.12) in kangaroo and 105.08 mg/g-dw (P=0.004) in porcine matrices. On electron microscopy calcific deposits were located between as well as in close association with the collagen fibers in all tissue. In contrast to the cross-linked gluteraldehyde fixed bioprostheses both matrices showed strong immune IgG reaction. Conclusion: Toronto SPV® valves calcified significantly less than the tested biological matrices irrespective of species of origin. Surprisingly, xenogenic decelullarized scaffolds are inherently prone to calcification due to a strong immunogenecity.

Key Words: Xenogenic scaffolds; Cross-links; Calcification; Immune response







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-thoracic Surgery